This firm currently holds 383.08
M in liabilities with Debt to Equity (D/E) ratio of 0.68, which is about average as compared to similar companies.
Our investment recommendation module provides unbiased trade recommendations that can be used to complement current
average analyst sentiment on Glaukos Corp. Our investment recommendation engine provides an advice for the firm potential to grow from the perspective of an investor's risk tolerance and investing horizon.
Glaukos Corp financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures the total debt position of Glaukos Corp, including all of Glaukos Corp's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Glaukos Corp assets, the company is considered highly leveraged. Understanding the
composition and structure of overall Glaukos Corp debt and outstanding corporate bonds gives a good idea of
how risky the capital structure of a business is and if it is worth investing in it. Please read more on our
technical analysis page.
Understanding Glaukos Total Liabilities
Glaukos Corp liabilities are broken down into two parts on the balance sheet. These are short-term (or current) obligations and long-term debt. Glaukos Corp has to fulfill its short-term liabilities in this reporting year and should be no more than 12 months old. Long-term debt, on the other hand, is anything beyond the 12-month payment timeframe. Common short-term liabilities found on Glaukos Corp balance sheet include debt obligations and money owed to different Glaukos Corp vendors, workers, and loan providers. Below is the chart of Glaukos short long-term liabilities accounts currently reported on its balance sheet.
You can use Glaukos Corp
financial leverage analysis tool to get a better grip on understanding its financial position
How important is Glaukos Corp's Liquidity
Glaukos Corp
financial leverage refers to using borrowed capital as a funding source to finance Glaukos Corp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Glaukos Corp financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Glaukos Corp's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Glaukos Corp's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Glaukos Corp's total debt and its cash.
A Deeper look at Glaukos
The latest price spike of Glaukos Corp may raise some interest from retail investors. The stock closed today at a share price of
56.30 on
1,291,100 in trading volume. The company management teams may have good odds in positioning the firm resources to exploit
market volatility in
October. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.35. The above-average risk is mostly attributed to
market volatility and speculations regarding some of the upcoming earning calls from Glaukos Corp partners.
Asset Breakdown
608.1 M
Assets Non Current
| Total Assets | 1.13 Billion |
| Current Assets | 524.5 Million |
| Assets Non Current | 608.06 Million |
| Goodwill | 430.41 Million |
| Tax Assets | 195,211 |
Our perspective of the latest Glaukos Corp fall
Latest semi variance is at 4.93.
As of the 10th of September, Glaukos Corp retains the
risk adjusted performance of 0.1431, and Market Risk Adjusted Performance of 0.2774. Glaukos Corp
technical analysis makes it possible for you to employ
historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to break down and interpolate data for nineteen
technical drivers for Glaukos Corp, which can be compared to its competitors. Please check out
Glaukos Corp coefficient of variation, as well as the
relationship between the treynor ratio and
semi variance to decide if Glaukos Corp is priced fairly, providing market reflects its last-minute price of 56.3 per share. Given that Glaukos Corp has
jensen alpha of 0.4416, we strongly advise you to confirm Glaukos Corp's regular market performance to make sure the company can sustain itself at a future point.
While few other entities in the medical devices industry are either recovering or due for a correction, Glaukos Corp may not be performing as strong as the other in terms of long-term growth potentials. To conclude, as of the 10th of September 2022, we see that Glaukos Corp responds to the market. The enterprise is
fairly valued with
low chance of bankruptcy within the next 24 months. Our primary 90 days buy-hold-sell advice on the enterprise is
Strong Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Glaukos Corp. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
